ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

In Brief: Minna to Leave NCI For Texas Southwestern; Alexander Is Special Populations Branch Chief

February 22, 1991

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998